Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome-Positive (Ph plus ) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study

被引:0
作者
Mauro, Michael J. [1 ]
Cortes, Jorge E. [2 ]
Kantarjian, Hagop M. [2 ]
Shah, Neil P. [3 ]
Bixby, Dale [4 ]
Flinn, Ian W. [5 ]
O'Hare, Thomas [6 ]
Hu, Simin [8 ]
Rivera, Victor M. [8 ]
Clackson, Tim [8 ]
Turner, Christopher D. [8 ]
Haluska, Frank G. [8 ]
Druker, Brian J. [7 ]
Deininger, Michael W. [6 ,7 ]
Talpaz, Moshe [4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Sarah Cannon Res Inst, Nashville, TN USA
[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[8] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1016/j.clml.2014.06.069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
404
引用
收藏
页码:S137 / S138
页数:2
相关论文
共 50 条
  • [21] Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study
    Tanguy-Schmidt, Aline
    Rousselot, Philippe
    Chalandon, Yves
    Cayuela, Jean-Michel
    Hayette, Sandrine
    Vekemans, Marie-Christiane
    Escoffre, Martine
    Huguet, Francoise
    Rea, Delphine
    Delannoy, Andre
    Cahn, Jean-Yves
    Vernant, Jean-Paul
    Ifrah, Norbert
    Dombret, Herve
    Thomas, Xavier
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : 150 - 155
  • [22] Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Pemmaraju, Naveen
    Wierda, William
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Cortes, Jorge
    Garris, Rebecca
    Khoury, Joseph D.
    Jorgensen, Jeffrey
    Jain, Nitin
    Alvarez, Joie
    O'Brien, Susan
    Kantarjian, Hagop
    LANCET HAEMATOLOGY, 2018, 5 (12): : E618 - E627
  • [23] Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Konopleva, Marina
    Desikan, Sai Prasad Prasad
    Jain, Nitin
    Ravandi, Farhad
    Huang, Xuelin
    Wierda, William G.
    Borthakur, Gautam
    Sasaki, Koji
    Issa, Ghayas C.
    Alvarado, Yesid
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Thankachan, Jennifer
    Delumpa, Ricardo
    Milton, Anna
    Jabbour, Elias J.
    BLOOD, 2021, 138
  • [24] Ponatinib in Pediatric Patients with Philadelphia Chromosome-Positive Leukemia - Japanese Pediatric Leukemia/Lymphoma Study Group
    Kodama, Yuichi
    Sato, Atsushi
    Kato, Keisuke
    Kato, Motohiro
    Kawasaki, Hirohide
    Sakaguchi, Hirotoshi
    Hiramatsu, Hidefumi
    Kato, Itaru
    Taga, Takashi
    Shimada, Hiroyuki
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [25] Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment
    Douet-Guilbert, N
    Morel, F
    Le Charpentier, T
    Le Bris, MJ
    Herry, A
    Morice, P
    Bourquard, P
    Abgrall, JF
    Berthou, C
    De Braekeleer, M
    ANTICANCER RESEARCH, 2004, 24 (04) : 2535 - 2539
  • [26] Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
    DS Snyder
    AP Nademanee
    MR O’Donnell
    PM Parker
    AS Stein
    K Margolin
    G Somlo
    A Molina
    R Spielberger
    A Kashyap
    H Fung
    ML Slovak
    A Dagis
    RS Negrin
    MD Amylon
    KG Blume
    SJ Forman
    Leukemia, 1999, 13 : 2053 - 2058
  • [27] Long-term follow-up of 14 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission
    Mizuta, Shuichi
    Kohno, Akio
    Morishita, Yoshihisa
    Atsuta, Yoshiko
    Sao, Hiroshi
    Miyamura, Koichi
    Sakamaki, Hisashi
    Ueda, Ryuzo
    Morishima, Yasuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (02) : 140 - 145
  • [28] Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
    Snyder, DS
    Nademanee, AP
    O'Donnell, MR
    Parker, PM
    Stein, AS
    Margolin, K
    Somlo, G
    Molina, A
    Spielberger, R
    Kashyap, A
    Fung, H
    Slovak, ML
    Dagis, A
    Negrin, RS
    Amylon, MD
    Blume, KG
    Forman, SJ
    LEUKEMIA, 1999, 13 (12) : 2053 - 2058
  • [29] LONG-TERM EFFICACY AND CARDIAC, VASCULAR AND HYPERTENSION SAFETY OF BOSUTINIB IN PREVIOUSLY TREATED PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE LEUKEMIA
    Gambacorti-Passerini, C.
    Bruemmendorf, T. H.
    Kim, D. -W.
    Mauro, M. J.
    Aguiar, J.
    Viqueira, A.
    Leip, E.
    Cortes, J. E.
    HAEMATOLOGICA, 2018, 103 : S97 - S98
  • [30] Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results
    Nasnas, Patrice
    Jabbour, Elias
    Short, Nicholas
    Sasaki, Koji
    Ravandi, Farhad
    Jain, Nitin
    Daver, Naval
    Pemmaraju, Naveen
    Yilmaz, Musa
    Kadia, Tapan M.
    Garris, Rebecca
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Konopleva, Marina
    Wierda, William G.
    Kwari, Monica
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Banks, Glenda
    Kantarjian, Hagop
    BLOOD, 2022, 140 : 3250 - 3252